Analgesics in the US - New Market Research Report
After two years of recalls from Johnson & Johnson's McNeil consumer health subsidiary, 2012 was expected to be a year of recovery in analgesics. Instead, production failures grew even more widespread. Novartis announced its own major recalls, including the popular analgesic brand Excedrin, after being forced to temporarily close its Lincoln, Nebraska manufacturing plant in December 2011. Meanwhile, McNeil recalled additional products, including Infants' Tylenol in February 2012. After having to...
View full press release